Kestra Medical Technologies, Ltd. - Common Stock (KMTS)

Revenue surged 66% in Q4 as prescriptions climbed 63% year over year.

Kestra Medical Technologies (NASDAQ:KMTS) reported a sharp increase in fourth-quarter revenue and issued fiscal 2027 guidance calling for continued growth, as executives said demand for the company’s ASSURE wearable cardioverter defibrillator system is being driven by new accounts, deeper penetratio

This cardiac device innovator saw a notable insider sale, as routine portfolio moves continue amid its push in digital health solutions.

This clinical-stage biotech develops bifunctional antibody therapies targeting solid tumors for oncology providers and institutions.

Alumis Inc. develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases using allosteric TYK2 inhibitors.

Kestra Medical Technologies develops advanced wearable cardiac devices and digital health solutions for cardiovascular care providers.

Kestra Medical Technologies, a specialist in wearable cardiac devices, reported a recent insider buy amid a year of share price declines.

Kestra Medical (KMTS) Q3 2026 Earnings Transcript

Kestra Medical (KMTS) Q2 2026 Earnings Transcript

Kestra Medical beats Q2 2026 revenue estimates but posts a wider-than-expected loss, triggering a sharp after-hours stock decline.

The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.

Kestra Medical beats Q1 FY26 revenue and EPS estimates, sending its stock up nearly 9% in after-hours trading on strong operational performance.

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Shares of Nvidia-backed CoreWeave opened for trading on Friday, raising $1.5 billion and making it the biggest U.S. tech IPO since 2021, even after it was priced below the expected range.

Shares of Kestra Medical, a wearable cardiac device maker, soared in the company's public debut this week. Meanwhile, Discord is said to be in talks for a possible IPO in 2025.